A Randomized, Open Label Clinical Trial to Evaluate if Nestorone Gel Has Gonadotropin Suppressive Activity and if Nestorone in Combination With Testosterone Will Have an Additive Effect on Gonadotropin Suppression When Applied Transdermally in Healthy Men.

Trial Profile

A Randomized, Open Label Clinical Trial to Evaluate if Nestorone Gel Has Gonadotropin Suppressive Activity and if Nestorone in Combination With Testosterone Will Have an Additive Effect on Gonadotropin Suppression When Applied Transdermally in Healthy Men.

Completed
Phase of Trial: Phase I

Latest Information Update: 25 Aug 2009

At a glance

  • Drugs Elcometrine (Primary) ; Testosterone
  • Indications Hypogonadism; Pregnancy
  • Focus Pharmacodynamics
  • Acronyms NES-1
  • Most Recent Events

    • 02 Nov 2007 Trial identifier HHSN27500002 added as reported by ClinicalTrials.gov.
    • 27 Jun 2007 Acronym identified NES-1 added as reported by ClinicalTrials.gov.
    • 07 May 2007 Actual patient number (140) added as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top